Active ingredientCilostazolCat. No. P-C163-001CAS 73963-72-1Family · Pharmaceutical analytical standards
Cilostazol
A phosphodiesterase 3 (PDE3) inhibitor with antiplatelet and vasodilating effects, approved in Japan in 1988 for symptoms of peripheral arterial disease, then in the United States in 1999 and in the UK in 2001 for intermittent claudication, leg pain when walking. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Besides inhibiting PDE3 it also blocks the uptake of adenosine by cells, a dual action that sets it apart from other PDE3 inhibitors such as milrinone.
Go to the active ingredient →Active ingredientCilostazolCat. No. P-C163-001CAS 73963-72-1
Pharmacopoeial impurityCilostazol USP Related Compound ACat. No. P-C163-002CAS 54197-66-9
Pharmacopoeial impurityCilostazol USP Related Compound BCat. No. P-C163-003CAS 73963-62-9
Pharmacopoeial impurityCilostazol USP Related Compound CCat. No. P-C163-004CAS 865792-18-3
Metabolite4-trans-Hydroxy CilostazolCat. No. P-C163-005CAS 87153-04-6
Isotopically labelled3,4-Dehydro Cilostazol-d11Cat. No. P-C163-006CAS 1073608-13-5
Isotopically labelledCilostazol Impurity 4-d5Cat. No. P-C163-007
Isotopically labelledCilostazol Impurity 10-13C-d3Cat. No. P-C163-008
Isotopically labelledCilostazol Impurity 11-d8Cat. No. P-C163-009
Isotopically labelledCilostazol Impurity 12-d4Cat. No. P-C163-010
Isotopically labelledCilostazol Impurity 9-d11Cat. No. P-C163-011
Isotopically labelledCilostazol-d11Cat. No. P-C163-013CAS 1073608-02-2
Isotopically labelledCilostazol-d4Cat. No. P-C163-014CAS 1215541-47-1
NitrosamineN-Nitroso CilostazolCat. No. P-C163-015
Impurity3,3-Dichloropropanoic acidCat. No. P-C163-016CAS 22716-03-6
Impurity3-Azidopropanoic acidCat. No. P-C163-017CAS 18523-47-2
Impurity4-(1-cyclohexyltetrazol-5-yl)butan-1-olCat. No. P-C163-018CAS 934533-78-5
ImpurityCilostazol Impurity 1 (>85%)Cat. No. P-C163-019CAS 1796891-27-4
Impurity4-cis-Hydroxy CilostazolCat. No. P-C163-020CAS 87153-06-8
Isotopically labelled4-cis-Hydroxy Cilostazol-d5Cat. No. P-C163-021
Isotopically labelled4-trans-Hydroxy Cilostazol-d5Cat. No. P-C163-022
Impurity5-(4-Chlorobutyl)-1-cyclohexyltetrazoleCat. No. P-C163-023CAS 73963-42-5
Impurity5-Azidopentanoic AcidCat. No. P-C163-024CAS 79583-98-5
Impurity5-Chloro-3,4-dihydroquinolin-2(1H)-oneCat. No. P-C163-025CAS 72995-15-4
Impurity5-Chloro-N-cyclohexylpentanamideCat. No. P-C163-026CAS 15865-18-6
ImpurityCilostazol Impurity 2Cat. No. P-C163-027CAS 940062-34-0
ImpurityCilostazol Impurity 3Cat. No. P-C163-028CAS 54197-64-7
ImpurityCilostazol DimerCat. No. P-C163-029CAS 2115698-98-9
ImpurityCilostazol Impurity 4Cat. No. P-C163-030
ImpurityCilostazol Impurity 5Cat. No. P-C163-031
ImpurityCilostazol Impurity 6Cat. No. P-C163-032
ImpurityCilostazol Impurity 7Cat. No. P-C163-033CAS 934533-79-6
ImpurityCilostazol Impurity 8Cat. No. P-C163-034CAS 1797509-92-2
ImpurityCilostazol Impurity 9Cat. No. P-C163-035
ImpurityCilostazol Metabolite OPC-3930Cat. No. P-C163-036CAS 73963-46-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.